Operationalization and measurement of compulsivity across video gaming and gambling behavioral domains.

Behavioral addiction Compulsivity Gambling Measurement Scale Self-report Validation Video gaming

Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 11 05 2023
accepted: 10 11 2023
medline: 23 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Compulsivity is the hallmark of addiction progression and, as a construct, has played an important role in unveiling the etiological pathways from learning mechanisms underlying addictive behavior to harms resulting from it. However, a sound use of the compulsivity construct in the field of behavioral addictions has been hindered to date by the lack of consensus regarding its definition and measurement. Here we capitalize on a previous systematic review and expert appraisal to develop a compulsivity scale for candidate behavioral addictions (the Granada Assessment for Cross-domain Compulsivity, GRACC). The initial scale (GRACC90) consisted of 90 items comprising previously proposed operationalizations of compulsivity, and was validated in two panel samples of individuals regularly engaging in gambling and video gaming, using exploratory structural equation modeling (ESEM) and convergence analyses. The GRACC90 scale is unidimensional and structurally invariant across samples, and predicted severity of symptoms, lower quality of life, and negative affect, to similar degrees in the two samples. Additionally, poorer quality of life and negative affect were comparably predicted by compulsivity and by severity of symptoms. A shorter version of the scale (GRACC18) is proposed, based on selecting the 18 items with highest factor loadings. Results support the proposal that core symptoms of behavioral addictions strongly overlap with compulsivity, and peripheral symptoms are not essential for their conceptualization. Further research should clarify the etiology of compulsive behavior, and whether pathways to compulsivity in behavioral addictions could be common or different across domains.

Sections du résumé

BACKGROUND BACKGROUND
Compulsivity is the hallmark of addiction progression and, as a construct, has played an important role in unveiling the etiological pathways from learning mechanisms underlying addictive behavior to harms resulting from it. However, a sound use of the compulsivity construct in the field of behavioral addictions has been hindered to date by the lack of consensus regarding its definition and measurement. Here we capitalize on a previous systematic review and expert appraisal to develop a compulsivity scale for candidate behavioral addictions (the Granada Assessment for Cross-domain Compulsivity, GRACC).
METHODS METHODS
The initial scale (GRACC90) consisted of 90 items comprising previously proposed operationalizations of compulsivity, and was validated in two panel samples of individuals regularly engaging in gambling and video gaming, using exploratory structural equation modeling (ESEM) and convergence analyses.
RESULTS RESULTS
The GRACC90 scale is unidimensional and structurally invariant across samples, and predicted severity of symptoms, lower quality of life, and negative affect, to similar degrees in the two samples. Additionally, poorer quality of life and negative affect were comparably predicted by compulsivity and by severity of symptoms. A shorter version of the scale (GRACC18) is proposed, based on selecting the 18 items with highest factor loadings.
CONCLUSIONS CONCLUSIONS
Results support the proposal that core symptoms of behavioral addictions strongly overlap with compulsivity, and peripheral symptoms are not essential for their conceptualization. Further research should clarify the etiology of compulsive behavior, and whether pathways to compulsivity in behavioral addictions could be common or different across domains.

Identifiants

pubmed: 37990335
doi: 10.1186/s40359-023-01439-1
pii: 10.1186/s40359-023-01439-1
pmc: PMC10664636
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : PRE2018-085150
Organisme : Ministerio de Ciencia e Innovación
ID : PID2020-116535 GB-I00

Informations de copyright

© 2023. The Author(s).

Références

Neurosci Biobehav Rev. 2021 Jan;120:455-469
pubmed: 33115636
Psychol Addict Behav. 2019 Aug;33(5):495-502
pubmed: 31219264
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Addiction. 2014 Sep;109(9):1399-406
pubmed: 24456155
Clin Psychol Rev. 2016 Feb;43:58-66
pubmed: 26704173
J Behav Addict. 2022 Mar 1;:
pubmed: 35234660
Addict Behav Rep. 2017 May 18;6:15-38
pubmed: 29450234
J Behav Addict. 2017 Mar 1;6(1):11-20
pubmed: 28264590
Nat Rev Neurosci. 2020 May;21(5):247-263
pubmed: 32231315
Psychol Addict Behav. 2020 Feb;34(1):182-193
pubmed: 31599604
CNS Spectr. 2020 Aug;25(4):519-526
pubmed: 31645228
Behav Brain Res. 2020 May 27;386:112598
pubmed: 32184156
J Gambl Stud. 2009 Mar;25(1):93-104
pubmed: 18592357
Biol Psychiatry. 2019 Jun 1;85(11):936-945
pubmed: 30737015
N Engl J Med. 2018 Oct 18;379(16):1551-1560
pubmed: 30332573
CNS Spectr. 2018 Oct;23(5):340-346
pubmed: 29730994
Addiction. 2016 Jan;111(1):167-75
pubmed: 26669530
Addict Behav. 2022 Nov;134:107410
pubmed: 35780595
Exp Clin Psychopharmacol. 2022 Aug;30(4):424-431
pubmed: 35511535
PLoS One. 2020 Oct 23;15(10):e0240726
pubmed: 33095762
Prog Brain Res. 2017;235:177-218
pubmed: 29054288
PLoS One. 2019 Feb 22;14(2):e0212695
pubmed: 30794642
Front Psychol. 2019 Apr 26;10:931
pubmed: 31133919
J Behav Addict. 2017 Dec 1;6(4):669-677
pubmed: 29280393
Transl Psychiatry. 2017 Jan 3;7(1):e992
pubmed: 28045460
Addiction. 2019 Jun;114(6):1095-1109
pubmed: 30133930
Annu Rev Neurosci. 2008;31:359-87
pubmed: 18558860
Psychiatry Res. 2018 Mar;261:581-588
pubmed: 29407726
Addict Behav. 2023 Jan;136:107496
pubmed: 36174423
Neuropsychol Rev. 2019 Mar;29(1):4-13
pubmed: 31016439
Am J Psychiatry. 2003 Jan;160(1):180-2
pubmed: 12505822
Psychiatry Clin Neurosci. 2017 Jul;71(7):459-466
pubmed: 27278653
Behav Res Methods. 2019 Feb;51(1):409-428
pubmed: 29869222
Biomed Res Int. 2014;2014:167438
pubmed: 25057479
J Behav Addict. 2020 Jul 23;9(3):617-628
pubmed: 32750032
Int J Environ Res Public Health. 2020 Feb 28;17(5):
pubmed: 32121280
Biol Psychiatry. 2020 Jan 1;87(1):44-53
pubmed: 31400808
J Behav Addict. 2014 Dec;3(4):203-13
pubmed: 25592305
Addiction. 2021 Sep;116(9):2463-2475
pubmed: 33449441
Clin Psychol Rev. 2014 Jun;34(4):298-308
pubmed: 24786896
Curr Behav Neurosci Rep. 2019 Sep;6(3):59-71
pubmed: 31396472
J Behav Addict. 2022 Jul 13;11(2):210-215
pubmed: 35895452
J Affect Disord. 2022 Nov 15;317:403-408
pubmed: 36029881
J Behav Addict. 2015 Sep;4(3):119-23
pubmed: 26014667
Neurosci Biobehav Rev. 2020 Jan;108:771-780
pubmed: 31846653
Psychol Methods. 2013 Dec;18(4):454-74
pubmed: 23046000

Auteurs

Ismael Muela (I)

Department of Experimental Psychology; Mind, Brain and Behavior Research Center (CIMCYC), University of Granada, 18071, Campus de Cartuja s/n, Granada, Spain. imuela@ugr.es.

Juan F Navas (JF)

Department of Clinical Psychology, Complutense University of Madrid, Madrid, Spain.

Juan R Barrada (JR)

Department of Psychology and Sociology, Faculty of Education, Universidad de Zaragoza, Zaragoza, Spain.

José López-Guerrero (J)

Department of Experimental Psychology; Mind, Brain and Behavior Research Center (CIMCYC), University of Granada, 18071, Campus de Cartuja s/n, Granada, Spain.

Francisco J Rivero (FJ)

Department of Experimental Psychology; Mind, Brain and Behavior Research Center (CIMCYC), University of Granada, 18071, Campus de Cartuja s/n, Granada, Spain.

Damien Brevers (D)

Louvain Experimental Psychopathology Research Group (LEP), Psychological Sciences Research Institute (IPSY), UCLouvain, Louvain-La-Neuve, Belgium.

José C Perales (JC)

Department of Experimental Psychology; Mind, Brain and Behavior Research Center (CIMCYC), University of Granada, 18071, Campus de Cartuja s/n, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH